Emcure Pharmaceuticals Ltd
Filgrastim (300mcg)
Emgrast 300mcg Injection is used to prevent infections after chemotherapy. It is a growth factor that stimulates the bone marrow to produce white blood cells.
Injection
Emgrast 300mcg Injection is given as an injection by a qualified medical professional. You should continue to take as long as your doctor advises for it. The duration of treatment varies according to your need and response to treatment. You might be asked to get regular tests done to check the number of blood cells in your blood and your bone density level while you are taking this medicine.
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Emgrast 300mcg Injection is a growth factor that stimulates the bone marrow to produce white blood cells. These cells protect the body against infections.
Emgrast 300mcg Injection reduces the risk of infection in people treated with chemotherapy. It is usually given as a daily injection into the tissue just under the skin or into the vein. You will normally receive your first dose at least 24 hours after your chemotherapy or bone marrow transplant. Store it in the refrigerator, protect it from light, and don't shake it. For a more comfortable injection, leave the syringe at room temperature for 30 minutes before using it. Pain or redness in the area of injection is common. Let your doctor know if you notice a lump, swelling, or bruising that doesn't go away. Use caution while driving or doing anything that requires concentration as Emgrast 300mcg Injection may cause dizziness. Your doctor may get regular tests done to monitor the number of blood cells in your blood and your bone density level while you are receiving treatment with this medicine. Stop taking Emgrast 300mcg Injection and inform your doctor if you have a fever, shortness of breath, fast rate of breathing or trouble breathing.
Emgrast 300mcg Injection is generally considered safe when used at the prescribed dose and for the duration recommended by your healthcare provider.
Emgrast 300mcg Injection works by stimulating the bone marrow to produce neutrophils, a type of white blood cell that helps fight infections.
Emgrast 300mcg Injection is used during cancer treatment (chemotherapy), bone marrow transplantation, severe chronic neutropenia (low neutrophil count), neutropenia in patients with HIV infection, and before stem cell donation.
Emgrast 300mcg Injection is not known to cause cancer.
The exact reason for bone pain caused by Emgrast 300mcg Injection is not fully understood, but it is a common side effect reported by some patients.